Page last updated: 2024-11-02

pioglitazone and Pheochromocytoma, Extra-Adrenal

pioglitazone has been researched along with Pheochromocytoma, Extra-Adrenal in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, SW1
Choi, OK1
Chang, MS1
Shin, CS1
Park, KS1
Kim, SY1

Other Studies

1 other study available for pioglitazone and Pheochromocytoma, Extra-Adrenal

ArticleYear
Thiazolidinediones inhibit the growth of PC12 cells both in vitro and in vivo.
    Biochemical and biophysical research communications, 2008, Jun-27, Volume: 371, Issue:2

    Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Caspase 3; Cell Proliferation; Cyclin E; Cy

2008